KURA ONCOLOGY, INC. (KURA) Net income 2016–2025
KURA ONCOLOGY, INC. (KURA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$278.7MFY2025 · since FY2016: -$27.6M → -$278.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$278.7M | -60.2% |
| FY2024 | -$174.0M | -14.0% |
| FY2023 | -$152.6M | -12.4% |
| FY2022 | -$135.8M | -4.1% |
| FY2021 | -$130.5M | -45.6% |
| FY2020 | -$89.6M | -41.9% |
| FY2019 | -$63.1M | -4.5% |
| FY2018 | -$60.4M | -70.6% |
| FY2017 | -$35.4M | -28.6% |
| FY2016 | -$27.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KURA financial trends
KURA RevenueKURA Net marginKURA Gross profitKURA Gross marginKURA Operating incomeKURA Operating marginKURA Operating cash flowKURA Free cash flowKURA Capital expendituresKURA Return on equityKURA Stock buybacksKURA Dividends paidKURA Total assetsKURA Total liabilitiesKURA Shareholders’ equityKURA overview →